OVERVIEW
The market size for infectious disease diagnostics is projected to reach USD 21.12 billion in 2024, at a CAGR of 5.43% during the forecast period. Growth in this market is driven primarily by rising infectious disease prevalence, shifting focus from centralized laboratories to decentralized point-of-care testing, and increasing funding for research on diagnosis of infectious diseases.
TABLE OF CONTENT
1 Global Infectious Disease Diagnostics MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Infectious Disease Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Infectious Disease Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Infectious Disease Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Infectious Disease Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Infectious Disease Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Infectious Disease Diagnostics Market – By Product & Service (Market Size – & million/billion)
8.1 Assays, Kits, & Reagents
8.2 Instruments
8.3 Services and Software
9 Global Infectious Disease Diagnostics Market – By Disease Type
9.1 Hepatitis
9.2 HIV
9.3 HAIs
9.4 HPV
9.5 TB
9.6 Influenza
9.7 Other
10 Global Infectious Disease Diagnostics Market – By Technology
10.1 Immunodiagnostics
10.2 Clinical Microbiology
10.3 PCR
10.4 INAAT
10.5 DNA Sequencing & NGS
10.6 DNA Microarrays
10.7 Other
11 Global Infectious Disease Diagnostics Market – By End-User
11.1 Hospitals/Clinical Laboratories
11.2 Reference Laboratories
11.3 Physician Offices
11.4 Academic/Research Institutes
11.5 Other
12 Global Infectious Disease Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Infectious Disease Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Infectious Disease Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Abbott Laboratories
14.3 Becton, Dickinson and Company
14.4 Biomérieux SA
14.5 Bio-Rad Laboratories
14.6 Danaher Corporation
14.7 Diasorin
14.8 Luminex
14.9 Meridian Bioscience
14.10 Quidel
14.11 Roche Diagnostics
14.12 Company 11 & more
15 Global Infectious Disease Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations